Eris Lifesciences

quarterly
yearly
ParticularsJun '23Sep '23Dec '23Mar '24Jun '24
Revenue415.32416.69327.84361.69461.85
Expenses282.78296.77293.20319.94435.03
EBITDA159.54151.4777.8699.78128.54
EBIT139.38126.4749.7870.6482.99
Profit Before Tax132.54119.9234.6541.7526.82
Net Profit110.76117.8131.6639.5117.04
Financial Ratios
Operating Profit Margin39.46%37.65%24.65%30.03%28.62%
Net Profit Margin27.40%29.29%10.02%11.89%3.79%
Earning Per Share (Diluted)8.138.652.332.901.25
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.4.9
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ